Acquired Immune Deficiency Syndrome (AIDS) is a leading cause of death worldwide. HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) are key highly active antiretroviral therapy drugs in the clinical management of AIDS/HIV-1 infections. Our recent studies showed that indolylarylsulfones (IASs) bearing a cyclic moiety on the 2-carboxamide nitrogen, linked through a short spacer group, are endowed with potent antiretroviral activity. The new IASs 8-37 showed potent inhibition of the HIV-1 WT NL4-3 strain and of the mutant K103N, Y181C, Y188L and K103N-Y181C HIV-1 strains. Six racemic mixtures, 8, 23-25, 31 and 33, were separated into their pure enantiomers. Overall, the (R)-8 enantiomer bearing the chiral (α- methylbenzyl) was superior to the (S)-counterpart. IAS derivatives bearing the (S)-alanine unit, (S)-23 and (S,R)-25, were remarkably more potent than the corresponding (R)-enantiomers. Moreover, the use of compound 23 resulted in the protection hippocampal neuronal cells from the excitotoxic insult, while efavirenz did not contrast the neurotoxic effect of glutamate. These results highlight the chiral IASs as new NNRTIs with improved resistance profile against the mutant HIV-1 strains and reduced neurotoxic effects.

Masci, D., La Regina, G., Coluccia, A., Brancale, A., Estè Josè, A., Silvestri, R., Indolylarylsulfones as novel potent anti-HIV-1 agents, Relazione, in Book of Abstract, 9th Biology and Molecular Medicine PhD School Symposium (BeMM), (Roma, 13-13 November 2018), 9th Biology and Molecular Medicine PhD School Symposium, Roma 2018: 18-18 [http://hdl.handle.net/10807/195415]

Indolylarylsulfones as novel potent anti-HIV-1 agents

Masci, Domiziana
;
La Regina, Giuseppe;
2018

Abstract

Acquired Immune Deficiency Syndrome (AIDS) is a leading cause of death worldwide. HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) are key highly active antiretroviral therapy drugs in the clinical management of AIDS/HIV-1 infections. Our recent studies showed that indolylarylsulfones (IASs) bearing a cyclic moiety on the 2-carboxamide nitrogen, linked through a short spacer group, are endowed with potent antiretroviral activity. The new IASs 8-37 showed potent inhibition of the HIV-1 WT NL4-3 strain and of the mutant K103N, Y181C, Y188L and K103N-Y181C HIV-1 strains. Six racemic mixtures, 8, 23-25, 31 and 33, were separated into their pure enantiomers. Overall, the (R)-8 enantiomer bearing the chiral (α- methylbenzyl) was superior to the (S)-counterpart. IAS derivatives bearing the (S)-alanine unit, (S)-23 and (S,R)-25, were remarkably more potent than the corresponding (R)-enantiomers. Moreover, the use of compound 23 resulted in the protection hippocampal neuronal cells from the excitotoxic insult, while efavirenz did not contrast the neurotoxic effect of glutamate. These results highlight the chiral IASs as new NNRTIs with improved resistance profile against the mutant HIV-1 strains and reduced neurotoxic effects.
2018
Inglese
Book of Abstract, 9th Biology and Molecular Medicine PhD School Symposium (BeMM)
9th Biology and Molecular Medicine PhD School Symposium (BeMM)
Roma
Relazione
13-nov-2018
13-nov-2018
9th Biology and Molecular Medicine PhD School Symposium
Comunicazione orale
Masci, D., La Regina, G., Coluccia, A., Brancale, A., Estè Josè, A., Silvestri, R., Indolylarylsulfones as novel potent anti-HIV-1 agents, Relazione, in Book of Abstract, 9th Biology and Molecular Medicine PhD School Symposium (BeMM), (Roma, 13-13 November 2018), 9th Biology and Molecular Medicine PhD School Symposium, Roma 2018: 18-18 [http://hdl.handle.net/10807/195415]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/195415
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact